SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950135-04-001684
Filing Date
2004-04-01
Accepted
2004-04-01 17:06:54
Documents
5
Period of Report
2004-03-17
Items
Item 2: Acquisition or disposition of assets
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 ANTIGENICS, INC. b49993age8vk.htm 8-K 57774
3 ASSET PURCHASE AGREEMENT b49993agexv2w1.txt EX-2.1 109132
4 1ST AMENDMENT TO ASSET PURCHASE AGREEMENT b49993agexv2w2.txt EX-2.2 12529
5 SUBLEASE b49993agexv10w1.txt EX-10.1 36619
6 1ST AMENDMENT TO SUBLEASE b49993agexv10w2.txt EX-10.2 24474
  Complete submission text file 0000950135-04-001684.txt   242662
Mailing Address 630 FIFTH AVENUE SUITE 2170 NEW YORK NY 10111
Business Address 630 FIFTH AVENUE SUITE 2170 NEW YORK NY 10111 2123324774
ANTIGENICS INC /DE/ (Filer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-29089 | Film No.: 04710360
SIC: 2836 Biological Products, (No Diagnostic Substances)